Status:
UNKNOWN
Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial
Lead Sponsor:
Ain Shams University
Conditions:
Iron Deficiency Anemia
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Anemia is the commonest hematological disorder that occurs in pregnancy. According to the recent standard laid down by 'WHO', anemia is present when the Hemoglobin (Hb) concentration in the peripheral...
Detailed Description
Anemia is the commonest hematological disorder that occurs in pregnancy. According to the recent standard laid down by 'WHO', anemia is present when the Hemoglobin (Hb) concentration in the peripheral...
Eligibility Criteria
Inclusion
- Pregnant women at 14 -18 weeks of gestation calculated from the first day of their last menstrual period and confirmed or modified by ultrasound
- Hemoglobin level 8-10.5 g/dL
- Serum ferritin\<15µg/L
Exclusion
- The presence of anemia from causes other than iron deficiency(e.g: Folat deficiency anemia,Vitamin B12 deficiency, ect…).
- Multiple gestations
- The presence of clinical and/or laboratory evidence of hepatic, renal, hematological or cardiovascular disease
- Patients with known gastritis
- History of mal-absorption syndrome
- Those with known hypersensitivity to iron preparations
- Those under current iron supplementation
Key Trial Info
Start Date :
February 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03830034
Start Date
February 2 2019
End Date
December 1 2019
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain shams university maternity hospital
Cairo, Egypt, 25187